Skip to main content
NCBI home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 1999 Jan;14(1):40–48. doi: 10.1007/BF02869150

The relevance of apolipoprotein E polymorphism to Alzheimer's disease

Sheshadri Narayanan 1,✉
PMCID: PMC3453560  PMID: 23105201

Abstract

The apo E gene located on chromosome 19 in humans is polymorphic. The three apo E isoforms E2, E3, and E4 are coded by three common alleles of the gene. The amyloid plaques in brains of Alzheimer disease (AD) patients are known to contain apo E. There is an increased prevalence of E4 allele in AD patients. apo E exhibits increased binding to a peptide Aβ deriving from amylold precursor protein. apo E, the risk factor for late AD disease is unable to prevent formation of paired helical filaments which in turn destabilizes neuronal microtubules.

A variety of molecular techniques are available for apo E genotyping using DNA amplified by the polymerase chain reaction (PCR). The high guanine to cytosine content of apo E is problematic to the extent that the yield of PCR product and hybridization stringency can be compromised. The specificity of diagnosis of late-onset AD can be improved when results of apo E genotyping are evaluated together with clinical criteria.

Full Text

The Full Text of this article is available as a PDF (560.8 KB).

References

  • 1.Mahley R.W. Apolipoprotein E: Cholesterol transport protein with expanding role in cell Biology. Science. 1988;240:622–630. doi: 10.1126/science.3283935. [DOI] [PubMed] [Google Scholar]
  • 2.Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 1985;76:1501–1513. doi: 10.1172/JCI112130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Roses A.D. Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequences. Ann. N.Y. Acad. Sci. 1996;802:50–57. doi: 10.1111/j.1749-6632.1996.tb32598.x. [DOI] [PubMed] [Google Scholar]
  • 4.Boerwinkle E., Visvikis S., Welsh D., Steinmetz J., Hanash S.M., Sing C.F. The use of measured genotype information in the analysis of quantitative phenotypes in Man. II. The role of apolipoprotein polymorphism in determining levels, variability and covariability of cholesterol, beta lipoprotein and triglycerides in a sample of unrelated individuals. Am. J. Hum. Genet. 1987;27:567–582. doi: 10.1002/ajmg.1320270310. [DOI] [PubMed] [Google Scholar]
  • 5.Corder E.H., Saunders A.M., Strittmatter D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of alzheimer's disease in late onset families. Science. 1993;261:921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  • 6.Hyman B.T., Tanzi R. Molecular epidemiology of alzheimer's disease. New Engl. J. Med. 1995;333:1283–1284. doi: 10.1056/NEJM199511093331910. [DOI] [PubMed] [Google Scholar]
  • 7.Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniemi A., Niinisto L., Halonen P., Kontula K. Apolipoprotein E, Dementia, and cortical deposition of β amyloid protein. New Engl. J. Med. 1995;333:1242–1247. doi: 10.1056/NEJM199511093331902. [DOI] [PubMed] [Google Scholar]
  • 8.Mahley R.W., Nathan B.P., Pitas R.E. Apolipoprotein E structure, function and possible roles in Alzheimer's disease. Ann. N.Y. Acad. Sci. 1996;777:139–145. doi: 10.1111/j.1749-6632.1996.tb34412.x. [DOI] [PubMed] [Google Scholar]
  • 9.Goedert M. Tau protein and the neurofibrillary pathology of alzheimer's disease. Ann. N.Y. Acad. Sci. 1996;777:121–131. doi: 10.1111/j.1749-6632.1996.tb34410.x. [DOI] [PubMed] [Google Scholar]
  • 10.Beffert U., Poirier J. Apolipoprotein E, Plaques, tangles and cholinergic dysfunction in alzheimer's disease. Ann. N.Y. Acad. Sci. 1996;777:166–174. doi: 10.1111/j.1749-6632.1996.tb34415.x. [DOI] [PubMed] [Google Scholar]
  • 11.Hyman B.T., Gomez-Isla T., West H., Briggs M., Chung H., Growdon J.H., Rebek G.W. Clinical and neuro pathological correlates of apolipoprotein E genotype in alzheimer's disease. Window on molecular epidemiology. Ann. N.Y. Acad. Sci. 1996;777:158–165. doi: 10.1111/j.1749-6632.1996.tb34414.x. [DOI] [PubMed] [Google Scholar]
  • 12.Bolla M.K., Haddad L., Humphries S.E., Winder A.F., Day I.N.M. High-throughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresis. Clin. Chem. 1995;41:1599–1604. [PubMed] [Google Scholar]
  • 13.Narayanan S. Concepts, Principles, and Applications of Selected Molecular Biology techniques in Clinical Biochemistry. Adv. Clin. Chem. 1996;32:1–38. doi: 10.1016/S0065-2423(08)60424-2. [DOI] [PubMed] [Google Scholar]
  • 14.Ballering L.A.P., Steffens-Nakken H.M., Esselink R.A.J., Devos R.A.I., Jansen Steur E.N.H., Vermes I. Apolipoprotein E genotyping in patients with neurodegenerative diseases. Clin. Biochem. 1997;30:405–411. doi: 10.1016/S0009-9120(97)00003-9. [DOI] [PubMed] [Google Scholar]
  • 15.Aozaki R., Kawaguchi R., Ogasa U., Hikiji K., Kubo N., Sakurabayashi I. Rapid identification of the common apo E isoform genotype using polymerase chain reaction—single strand conformation polymorphism (PCR-SSCP) Mol. Cell. Probes. 1994;8:51–54. doi: 10.1006/mcpr.1994.1007. [DOI] [PubMed] [Google Scholar]
  • 16.Wenham P.R., Newton C.R., Price W.H. Analysis of apolipoprotein E genotypes by the amplification refractory mutation system. Clin. Chem. 1991;37:241–244. [PubMed] [Google Scholar]
  • 17.Donohoe G.G., Salomaki A., Lehtimaki T., Pulkki K., Kairisto V. Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clin. Chem. 1999;45:143–146. [PubMed] [Google Scholar]
  • 18.Miettinen H.E., Korpela K., Hamalainen L., Kontula K. Polymorphisms of the apolipoprotein and angiotensin coverting enzyme genes in young North Karelian patiens with coronary heart disease. Hum. Genet. 1994;94:189–192. doi: 10.1007/BF00202868. [DOI] [PubMed] [Google Scholar]
  • 19.Narayanan S. Preanalytical and analytical pitfalls in molecular biology techniques. J. Clin. Ligand Assay. 1997;20:200–205. [Google Scholar]
  • 20.Wenham P.R., Sedky A., Spooner R.J. Apolipoprotein E phenotyping: a word of caution. Ann. Clin. Biochem. 1991;28:599–605. doi: 10.1177/000456329102800610. [DOI] [PubMed] [Google Scholar]
  • 21.Snowden C., Houlston R.S., Arif M.H., Laker M.F., Humphries S.E., Alberti K.G. Disparity between apolipoprotein phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin-dependent diabetes mellitus. Clin. Chim. Acta. 1991;196:49–58. doi: 10.1016/0009-8981(91)90207-S. [DOI] [PubMed] [Google Scholar]
  • 22.Mayeux R., Sanders A.M., Shea S., Mirra S., Evans D., Roses A.D., Hyman B.T., Crain B., Tang M.X., Phelps C.H. Utility of apolipoprotein E genotype in the diagnosis of Alzheimer's disease. New Engl. J. Med. 1998;338:506–511. doi: 10.1056/NEJM199802193380804. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES